Literature DB >> 11375291

Analysis of volatile disease markers in blood.

W Miekisch1, J K Schubert, D A Vagts, K Geiger.   

Abstract

BACKGROUND: The diagnostic potential of breath analysis has been limited by a lack of knowledge on origin, distribution, and metabolism of the exhaled substances. To overcome this problem, we developed a method to assess trace amounts of hydrocarbons (pentane and isoprene), ketones (acetone), halogenated compounds (isoflurane), and thioethers (dimethyl sulfide) in the blood of humans and animals.
METHODS: Arterial and venous blood samples were taken from mechanically ventilated patients. Additional blood samples were taken from selected vascular compartments of 19 mechanically ventilated pigs. Volatile substances were concentrated by means of solid-phase microextraction (SPME), separated by gas chromatography, and identified by mass spectrometry.
RESULTS: Detection limits were 0.02-0.10 nmol/L. Venous concentrations in pigs were 0.2-1.3 nmol/L for isoprene, 0-0.3 nmol/L for pentane, and 1.2-15.1 nmol/L for dimethyl sulfide. In pigs, substances were not equally distributed among vascular compartments. In humans, median arteriovenous concentration differences were 3.58 nmol/L for isoprene and 1.56 nmol/L for pentane. These values were comparable to pulmonary excretion rates reported in the literature. Acute respiratory distress syndrome (ARDS) patients had lower isoprene concentration differences than patients without ARDS.
CONCLUSIONS: The SPME method can detect volatile substances in very low concentrations in the blood of humans and animals. Analysis of volatile substances in vascular compartments will enlarge the diagnostic potential of breath analysis.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11375291

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  15 in total

1.  Dependence of exhaled breath composition on exogenous factors, smoking habits and exposure to air pollutants.

Authors:  W Filipiak; V Ruzsanyi; P Mochalski; A Filipiak; A Bajtarevic; C Ager; H Denz; W Hilbe; H Jamnig; M Hackl; A Dzien; A Amann
Journal:  J Breath Res       Date:  2012-09       Impact factor: 3.262

2.  Mycobacterium tuberculosis pellicles express unique proteins recognized by the host humoral response.

Authors:  Patrick W Kerns; David F Ackhart; Randall J Basaraba; Jeff G Leid; Mark E Shirtliff
Journal:  Pathog Dis       Date:  2014-02-26       Impact factor: 3.166

Review 3.  The clinical potential of exhaled breath analysis for diabetes mellitus.

Authors:  Timothy Do Chau Minh; Donald Ray Blake; Pietro Renato Galassetti
Journal:  Diabetes Res Clin Pract       Date:  2012-03-10       Impact factor: 5.602

4.  Effect of age and storage conditions on the volatile organic compound profile of blood.

Authors:  Shari L Forbes; LaTara Rust; Kate Trebilcock; Katelynn A Perrault; Laura T McGrath
Journal:  Forensic Sci Med Pathol       Date:  2014-10-29       Impact factor: 2.007

5.  Blood and breath levels of selected volatile organic compounds in healthy volunteers.

Authors:  Paweł Mochalski; Julian King; Martin Klieber; Karl Unterkofler; Hartmann Hinterhuber; Matthias Baumann; Anton Amann
Journal:  Analyst       Date:  2013-02-25       Impact factor: 4.616

6.  Breath isoprene: muscle dystrophy patients support the concept of a pool of isoprene in the periphery of the human body.

Authors:  J King; P Mochalski; K Unterkofler; G Teschl; M Klieber; M Stein; A Amann; M Baumann
Journal:  Biochem Biophys Res Commun       Date:  2012-06-05       Impact factor: 3.575

7.  Breath analysis using laser spectroscopic techniques: breath biomarkers, spectral fingerprints, and detection limits.

Authors:  Chuji Wang; Peeyush Sahay
Journal:  Sensors (Basel)       Date:  2009-10-19       Impact factor: 3.576

8.  Exhaled volatile organic compounds in patients with non-small cell lung cancer: cross sectional and nested short-term follow-up study.

Authors:  Diana Poli; Paolo Carbognani; Massimo Corradi; Matteo Goldoni; Olga Acampa; Bruno Balbi; Luca Bianchi; Michele Rusca; Antonio Mutti
Journal:  Respir Res       Date:  2005-07-14

9.  Release and uptake of volatile organic compounds by human hepatocellular carcinoma cells (HepG2) in vitro.

Authors:  Paweł Mochalski; Andreas Sponring; Julian King; Karl Unterkofler; Jakob Troppmair; Anton Amann
Journal:  Cancer Cell Int       Date:  2013-07-17       Impact factor: 5.722

Review 10.  Integration of biosensors and drug delivery technologies for early detection and chronic management of illness.

Authors:  Mpho Ngoepe; Yahya E Choonara; Charu Tyagi; Lomas Kumar Tomar; Lisa C du Toit; Pradeep Kumar; Valence M K Ndesendo; Viness Pillay
Journal:  Sensors (Basel)       Date:  2013-06-14       Impact factor: 3.576

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.